Phibro Animal Health (PAHC) Other Accumulated Expenses (2013 - 2026)
Phibro Animal Health (PAHC) posted Other Accumulated Expenses of $29.9 million for Q2 2026, little changed on a QoQ basis from $29.9 million in Q1 2026, and down 4.17% year-over-year from $31.2 million in Q2 2025.
Analysis
Phibro Animal Health (PAHC) Other Accumulated Expenses (2013 - 2026) Analysis & Trends
Phibro Animal Health has reported Other Accumulated Expenses for 10 years, with the latest figure at $29.9 million in Q2 2026.
- On a quarterly basis, Other Accumulated Expenses fell 4.17% year-over-year to $29.9 million in Q2 2026; TTM through Jun 2026 was $29.9 million, a 4.17% decrease from a year earlier, with the FY2026 full-year figure at $29.9 million, down 4.17% from the prior year.
- Other Accumulated Expenses was $29.9 million for Q2 2026 at Phibro Animal Health, roughly flat from $29.9 million in the prior quarter.
- The five-year high for Other Accumulated Expenses was $46.8 million in Q4 2024, with the low at $17.5 million in Q2 2024.
- Average Other Accumulated Expenses over 5 years is $25.0 million, with a median of $20.2 million recorded in 2023.
- The largest YoY upside for Other Accumulated Expenses was 135.21% in 2025 against a maximum downside of 37.77% in 2025.
- Over 5 years, Other Accumulated Expenses stood at $18.5 million in 2022, then grew by 12.83% to $20.9 million in 2023, then surged by 124.05% to $46.8 million in 2024, then tumbled by 37.77% to $29.1 million in 2025, then rose by 2.77% to $29.9 million in 2026.
- The last three Other Accumulated Expenses figures came in at $29.9 million (Q2 2026), $29.9 million (Q1 2026), and $29.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.93 Mn |
| Mar 31, 2026 | 29.87 Mn |
| Dec 31, 2025 | 29.13 Mn |
| Sep 30, 2025 | 29.53 Mn |
| Jun 30, 2025 | 31.24 Mn |
| Mar 31, 2025 | 41.74 Mn |
| Dec 31, 2024 | 46.81 Mn |
| Sep 30, 2024 | 18.19 Mn |
| Jun 30, 2024 | 17.54 Mn |
| Mar 31, 2024 | 17.75 Mn |
| Dec 31, 2023 | 20.89 Mn |
| Sep 30, 2023 | 19.59 Mn |
| Jun 30, 2023 | 18.86 Mn |
| Mar 31, 2023 | 19.60 Mn |
| Dec 31, 2022 | 18.52 Mn |
| Sep 30, 2022 | 17.90 Mn |
| Jun 30, 2022 | 18.90 Mn |
| Mar 31, 2022 | 23.33 Mn |
| Dec 31, 2021 | 18.39 Mn |
| Sep 30, 2021 | 17.95 Mn |